Harnessing HT metabolomics and phenotypic profiling for cancer research 

Metabolic profiling of cancer cell line collections has become an invaluable tool in the study of disease etiology and drug modes of action, as well as for selecting personalized treatments. However, its scale is limited by time-consuming sampling and complex measurement procedures. Discover how the Institute of Molecular Systems Biology at ETH Zurich has developed a high throughput metabolomics platform to overcome these bottlenecks, using timelapse microscopy to combine dynamic phenotypic and molecular profiling at high throughput.